reversed in 1 by the outcome classification committee because PE was found at autopsy 6 days after the angiogram. One patient had no angiogram, being in the arm of PIOPED that allowed angiography at the physician's request; the patient died of unrelated causes 4 days later and autopsy showed small peripheral PE.
Techniques of recruiting, physical examination, ventilation/ perfusion lung scans, pulmonary angiography, and follow-up were reported in PIOPED.4 Outcome assessment, treatment, and follow-up procedures were described by Carson and associates.3
Death and the presence of recurrent PE were assessed by an outcome-classification committee for 1 year after entry into the study. Cause of death was established after review of all available clinical information, findings at autopsy (if performed), and the patient's death certificate. Patients were classified as having died of PE if, in the opinion of the outcome classification committee, this condition was the immediate or underlying cause of death.
Diagnostic studies for recurrent PE were ordered by the attending physician on the basis of clinical suspicion and were not part of the study protocol. Recurrent PE was determined by the outcome classification committee on the basis of recent PE at autopsy of patients who survived the original PE, by angiographic demonstration of new thromboemboli on follow-up, by the development of new perfusion lung scan defects consistent with a high probability of PE, or by a convincing clinical presentation.
Among the untreated patients, three died in the hospital during the first week and five died during the first 3 months following hospital discharge ( Among 20 untreated patients, pleuritic pain in six (30%) was less frequent than in treated patients (Table 2). All other signs and symptoms occurred with comparable frequency between the two groups. The plain chest radiograph and electrocardiogram also showed no statistically significant differences of the frequency of abnormalities among treated and untreated patients (Table 2) . Pulmonary Artery Pressure, PaO2, and Alveolar Arterial Oxygen Gradient
The PaO2 while breathing room air was lower in untreated compared with treated patients (Table 3) . The alveolar arterial oxygen gradient while breathing room air was higher in untreated compared with treated patients. The pulmonary artery mean pressure did not show a statistically significant difference between untreated and treated patients (Table 3) . Ventilation/Perfusion Lung Scans Ventilation/perfusion lung scans were interpreted as high probability in a smaller percent of untreated patients with PE than treated patients, 0 of 20 (0%) vs 160 of 376 (43%) (p<0.001). Low probability, nearly normal, or normal ventilation/perfusion scans Table 4) . Only peripheral vessels were involved in 7 of 19 (37%) untreated patients and 13 of 362 (4%) treated patients (p<0.001). Thromboemboli were not observed on the angiogram of one untreated patient, but were shown at autopsy 6 days later.
Comparison of Results-Untreated and Treated

Patients
Death from the initial PE or fatal recurrent PE during the first 3 months after the initial PE occurred in 1 of 20 (5.0%) untreated patients and 9 of 376 (2.4%) treated patients (NS) ( Table 5) . Nonfatal recurrent PE during the 3 months of follow-up occurred in 1 of 20 (5.0%) untreated patients compared with 13 of 376 (3.5%) treated patients (NS). Total events (recurrent nonfatal PE, fatal recurrent PE, or death from the initial PE) occurred in 2 of 20 (10.0%) untreated patients compared with 22 of 376 (5.9%) treated patients (NS). There was no statistically significant difference of the frequency of fatal PE, fatal recurrent PE, and nonfatal recurrent PE among untreated patients and patients treated with full-dose anticoagulants, but not thrombolytic therapy, inferior vena cava interruption, or pulmonary embolectomy (Table 5) .
CHEST / 107 / 4 / APRIL, 1995 933 significant extent among untreated and treated paIn regard to the course of untreated PE over 1 year, tients, but the PaO2 was lower among untreated pa-0 of 19 untreated patients suffered recurrent PE tients compared with treated patients, and the alveduring the fourth through 12th months of observaolar arterial oxygen gradient was higher among tion. The frequency of death from the initial PE, fauntreated patients. tal recurrent PE, and nonfatal recurrent PE over the The course of untreated PE in these patients course of 1 year among untreated patients was 2 of appears to represent the course of mild PE. The fre- quency of fatal PE in these patients (5.0%) is strikingly lower than the mortality from PE reported in past decades."12 Hermann et al,2 based on autopsy findings, calculated a 37% mortality from the initial PE. The treatment of these patients was not reported. Barritt and Jordan,1 among untreated patients, reported a 26% mortality from the initial PE, although some of these patients perhaps died of recurrent PE.
Regarding recurrent PE among untreated patients, Hermann and associates2 reported a 36% frequency of fatal recurrent PE and a 21 % frequency of nonfatal recurrent PE. The lower mortality from the initial PE that we observed in untreated patients reflects the less severe PE. The lower frequency of recurrent PE that we observed presumably also relates to the milder severity of PE in these patients. The mortality of untreated mild PE was comparable to the mortality from fatal PE in untreated patients with subtle deep venous thrombosis, about 5% 6 The 3-month duration of follow-up that we primarily evaluated is the duration recommended for anticoagulant therapy in the absence of continuing risk factors. 7 The frequency of death from PE or nonfatal recurrent PE during this period was comparable among untreated and treated patients stratified according to the severity of the perfusion defect or size of vessels involved on the pulmonary angiogram. Inadequate treatment with antithrombotic agents had a negligible adverse effect on the results of treatment; only 4 of 376 (1.1%) treated patients received antithrombotic agents without the intention of achieving full anticoagulation. The statistically insignificant difference of fatal initial PE, fatal recurrent PE, or nonfatal recurrent PE among untreated patients with mild PE compared with treated patients with mild PE suggests a possible need for further evaluation of the risk-benefit ratio of anticoagulation treatment of mild PE.
